ALKS Alkermes Inc. plc Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
12:52
Aug 17
seedy19tron Biotech trader, L/S
Reports most closed positions across funds
"Reports most closed positions across specialist funds in Q2 2026 excluding M&A take-outs, no directional view."
ALKS
MED
11:57
Aug 17
seedy19tron Biotech trader, L/S
Reports most closed positions by specialist funds
Reports the most closed positions by specialist funds in Q2 2026, excluding M&A takeouts.
ALKS
MED
20:21
Jun 17
Bloomberg Newswire (@business)
Alkermes reports that its experimental drug improved wakefulness and reduced daytime sleepiness.
Alkermes reports that its experimental drug improved wakefulness and reduced daytime sleepiness in narcolepsy patients, suggesting a promising new class of medicines could help more patients than expected.
ALKS

About ALKS Analyst Coverage

Buzzberg tracks ALKS (Alkermes Inc. plc) across 2 sources. 0 bullish vs 0 bearish calls from 2 analysts. Sentiment: evenly split. 3 total trade ideas tracked. Latest voices: seedy19tron, Bloomberg.